425: Bellevue Life Sciences Amends Agreements for Business Combination and PIPE Investment

Bellevue Life Sciences Acquisition Corp. has amended its business combination agreement with OSR Holdings and its PIPE subscription agreement with Toonon Partners, modifying redemption features and put/call rights.

Summary

• Bellevue Life Sciences Acquisition Corp. (BLAC) has made amendments to two key agreements.
• The first amendment modifies the PIPE subscription agreement with Toonon Partners, removing redemption features of the Series A Preferred Stock.
• The second amendment modifies the business combination agreement with OSR Holdings, specifically adjusting the termination date for put and call rights in the Non-Participating Stockholder Joinder.
• The original PIPE agreement involved Toonon purchasing 222,222 shares of Series A Preferred Stock for $20 million, or $90 per share.
• The business combination agreement was initially entered into on November 16, 2023, and amended on May 23, 2024.
• The amendments were made on December 17, 2024, and December 20, 2024, respectively.
• A special committee of independent directors was formed to review and approve these agreements due to potential conflicts of interest.

Sentiment

Score: 7

Explanation: The document is primarily factual and reports on amendments to existing agreements. While there are risks mentioned, the overall tone is neutral to slightly positive, indicating progress in the business combination process. The removal of redemption rights is a positive for the company.

Positives

• The removal of redemption features from the Series A Preferred Stock may provide more stability for BLAC.
• The clarification of put and call rights termination dates provides more certainty for non-participating stockholders.
• The formation of an independent M&A committee demonstrates good corporate governance practices.

Risks

• The document mentions forward-looking statements that are subject to risks and uncertainties, including the possibility of the business combination not being completed.
• There are risks related to the impact of the COVID-19 pandemic on the business combination and OSR Holdings' business.
• The document also mentions the risk of not obtaining or maintaining the listing of the surviving company's stock on Nasdaq.
• There is a risk that the business combination could disrupt the current plans and operations of OSR Holdings.
• The document also mentions the risk of not being able to recognize the anticipated benefits of the proposed business combination.

Future Outlook

The document includes forward-looking statements regarding the completion of the business combination and the future performance of BLAC, but these are subject to significant risks and uncertainties.

Management Comments

• Kuk Hyoun Hwang, CEO of BLAC, signed the report on behalf of the company.
• Jin Whan Park, a member of the BLAC M&A Committee, signed the First Amendment to the Amended and Restated Business Combination Agreement.
• Sang Hoon Kim, CEO of OSR Holdings, also signed the First Amendment to the Amended and Restated Business Combination Agreement.

Industry Context

This announcement is typical for a special purpose acquisition company (SPAC) like BLAC, which is in the process of completing a business combination. The amendments to the agreements are likely part of the due diligence and negotiation process.

Comparison to Industry Standards

• The use of a PIPE (Private Investment in Public Equity) is a common practice for SPACs to secure additional funding for their business combinations.
• The formation of a special committee of independent directors to review potential conflicts of interest is a standard practice in corporate governance.
• The put and call rights are a common mechanism to protect the interests of non-participating stockholders in a business combination.
• The terms of the Series A Preferred Stock, including the dividend rate and conversion price, are within the typical range for such instruments in similar transactions.
• The document's risk disclosures are consistent with the requirements for SEC filings and are similar to those found in other SPAC merger announcements.

Corporate Governance

Stakeholder Impact

• Shareholders are urged to read the proxy statement for important information about the business combination.
• The amendments to the agreements may impact the value of the company's securities.
• The business combination will impact the future of the company and its stakeholders.

Next Steps

• BLAC will mail the definitive proxy statement to stockholders for voting on the proposed business combination.
• The business combination is subject to the satisfaction of closing conditions.
• The company will need to obtain stockholder approval for the issuance of common stock upon conversion of the Series A Preferred Stock.

Key Dates

Keywords

business combination, PIPE investment, preferred stock, subscription agreement, amendment, put right, call right, redemption, OSR Holdings, Toonon Partners